Publications

Members only publications are marked with a lock icon:
Filter By

A Randomized Trial of Alerting to Hypocholesterolemia Results of the Low Indexes of Metabolism Intervention Trial-C (LIMIT-C)

JAMDA
October 12, 2019
The benefit of alerting clinical staff to drug-induced hypocholesterolemia in patients aged 75 years and older remains uncertain.

Predictors of Incident Fear of Falling in Community-Dwelling Older Adults

JAMDA
October 11, 2019
Fear of falling (FoF) is common in older people and may lead to physical decline, disability, poor quality of life, and falls. Several risk factors for FoF have been identified in cross-sectional studies, but evidence on predictors of its incidence...

Be a Great Leader and Inspire Others

Spotlight
October 10, 2019
MEMBERS ONLY CONTENT Login or Join When practitioners look in the mirror, a growing number see themselves as agents of positive change; but they may not self-identify as leaders. “Leaders arise in all kinds of circumstances, and people can harness...

CMS and OIG Propose Stark Law and Anti-Kickback Statute Reforms

Policy Snapshot
Centers for Medicare and Medicaid (CMS), Federal Regulations, Practitioners
October 10, 2019
This week, the Department of Health and Human Services (HHS) announced proposed changes, by the Centers for Medicare & Medicaid Services (CMS) and the Office of the Inspector General (OIG), to modernize and clarify the regulations that interpret...

CMS Issues Changes to Nursing Home Compare to Focus on Abuse and Neglect

Policy Snapshot
Centers for Medicare and Medicaid (CMS), Quality, Resident
October 10, 2019
On October 7, the Centers for Medicare & Medicaid Services (CMS) announced a major change of the information available to nursing home residents, families, and caregivers on the Nursing Home Compare website. Beginning October 23, CMS will...

Register for CMS’ October 16 MIPS Eligible Measures Applicability Process Webinar

Policy Snapshot
Centers for Medicare and Medicaid (CMS), Medicare Access and CHIP Re-authorization Act (MACRA), Merit-Based Incentive Program Payment System (MIPS), Quality Payment Program (QPP), Practice Management, Practitioners
October 10, 2019
The Centers for Medicare & Medicaid Services (CMS) is hosting a webinar on Wednesday, October 16, from 2 to 3:30 PM ET to provide information about the Eligible Measures Applicability (EMA) process, which checks for additional clinically related...

Quality Payment Program: MIPS Dates and Deadlines

Policy Snapshot
Centers for Medicare and Medicaid (CMS), Payment, Medicare Access and CHIP Re-authorization Act (MACRA), Merit-Based Incentive Program Payment System (MIPS), Quality Payment Program (QPP), Practice Management, Practitioners
October 10, 2019
Important Merit-based Incentive Payment System (MIPS) dates and deadlines: December 31 – 2019 Promoting Interoperability Hardship Exception and Extreme and Uncontrollable Circumstances Applications deadline December 31 – 2020 virtual group election...

Lessons Learned From Implementation of the Indiana SMART Campaign to Reduce Nursing Home Polypharmacy

JAMDA
October 10, 2019
Polypharmacy among nursing home (NH) residents is prevalent, potentially hazardous, and can be reduced if prescribing guidelines and processes such as in-depth medication reviews are properly implemented.1–4 Given the known hazards of NH...

Safety of Subcutaneous Piperacillin/Tazobactam Administration Compared to Intravenous Administration: Propensity Score–Matched Cohort Study

JAMDA
October 10, 2019
Currently, the subcutaneous administration of antibiotics is considered to be an alternative route to intravenous administration because of its safety and effectiveness in treating bacterial infection,1 leading to its widespread use, especially for...

Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD

JAMDA
October 8, 2019
Benzodiazepines and related drugs (BDZRs) have been associated with an increased risk of Alzheimer's disease (AD) in later life. Despite this, it remains unclear whether ongoing BDZR use may further accelerate cognitive decline in those diagnosed...